Understanding the Effect of Rajyog Meditation on Biomolecular and Behavioural Co-relates of Stress in Patients Undergoing Coronary Artery Bypass Graft Surgery

Main Article Content

Kajal Yadav Minati Choudhury M Kalaivani Anushree Gupta


Background: The role of psychological health in impacting the risk factors for heart disease is well recognized. Patients undergoing corrective surgery for Coronary Artery Disease undergo much anxiety and depression that negatively impact the overall health of the heart. Higher levels of biomarkers that promote atherosclerosis is frequently found in individuals with negative psychological health. Improving psychological health can lead to healthier surgical outcome.  Various relaxation techniques including meditation are used to relax and reduce a person’s stress and anxiety and are gaining importance in peri-operative stress management procedures.

Aim: It was the aim of present study to evaluate the role of Rajyog meditation in bringing down surgery related stress levels in patients undergoing Coronary Artery Bypass Grafting Surgery. This was sought to be achieved by measuring the variations in their circulating plasma endothelin-1 levels (molecular stress marker) after being imparted with relaxation therapy in the form of meditation followed by association analysis with subjective indicators of stress.  

Design: Randomized controlled Trial

Setting: A total of 60 patients undergoing Coronary Artery Bypass Grafting Surgery, thirty each in non-intervention and intervention groups and fulfilling the inclusion criterion were enrolled in the study.

Intervention: Relaxation therapy in the form of Rajyoga Meditation was imparted for one month to patients only in the intervention group, before they underwent Coronary Artery Bypass Grafting Surgery.

Main outcome measures: Blood samples were collected before meditation, post-meditation/before surgery, post-meditation/after surgery and circulating plasma Endothelin-1 levels measured by sandwich ELISA. Clinical parameters were determined based on analysis of compiled questionnaires.

Results: The sleep quality improved and anxiety levels reduced after meditation (p = 0.002 and p= 0.005 respectively) in the intervention group as a whole. There was a drop in median plasma Endothelin-1 levels from 1.68 pg/ml to 1.38 pg/ml after meditation in the intervention group and a concomitant rise of median plasma Endothelin-1 levels from 1.0 pg/ml to 2.05 pg/ml in the non-intervention group.

Conclusions: The findings suggest that Rajyog meditation can bring about a beneficial difference in the subjective clinical parameters of patients and also a drop in plasma Endothelin-1 levels distinct from a rise in its levels in the non-intervention group.

Article Details

How to Cite
YADAV, Kajal et al. Understanding the Effect of Rajyog Meditation on Biomolecular and Behavioural Co-relates of Stress in Patients Undergoing Coronary Artery Bypass Graft Surgery. Medical Research Archives, [S.l.], v. 12, n. 1, feb. 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5000>. Date accessed: 03 mar. 2024. doi: https://doi.org/10.18103/mra.v12i1.5000.
Research Articles


1. Fuchs FD, Whelton PK. High Blood Pressure and Cardiovascular Disease. Hypertension. 2020;75(2):285-292.
2. Underwood MJ, Firmin RK, Jehu D. Aspects of psychological and social morbidity in patients awaiting coronary artery bypass grafting. Br Heart J. 1993;69(5):382-384.
3. Maini S. Effect of Rajyoga Meditation on the Heart Rate, Blood Pressure and ECG. Journal of Clinical and Diagnostic Research. 2011;5(8):1519-1522.
4. Kiran U, Ladha S, Makhija N, et al. The role of Rajyoga meditation for modulation of anxiety and serum cortisol in patients undergoing coronary artery bypass surgery: A prospective randomized control study. Ann Card Anaesth. 2017;20(2):158-162.
5. Lang R, Dehof K, Meurer KA, Kaufmann W. Sympathetic activity and transcendental meditation. J Neural Transm. 1979;44(1-2):117-135.
6. Cuthbert B, Kristeller J, Simons R, Hodes R, Lang PJ. Strategies of arousal control: biofeedback, meditation, and motivation. J Exp Psychol Gen. 1981;110(4):518-546.
7. Brook RD, Appel LJ, Rubenfire M, et al. Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension. 2013;61(6):1360-1383.
8. Anderson JW, Liu C, Kryscio RJ. Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens. 2008;21(3):310-316.
9. Patel C, Marmot MG, Terry DJ, Carruthers M, Hunt B, Patel M. Trial of relaxation in reducing coronary risk: four year follow up. Br Med J (Clin Res Ed). 1985;290(6475):1103-1106.
10. Benson H. Hypnosis and the relaxation response. Gastroenterology. 1989;96(6):1609-1611.
11. Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis. 2009;202(2):321-329.
12. Mendez Hernandez R, Ramasco Rueda F. Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence. J Pers Med. 2023;13(2).
13. Pousset F, Isnard R, Lechat P, et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J. 1997;18(2):254-258.
14. Wilbert-Lampen U, Nickel T, Leistner D, et al. Modified serum profiles of inflammatory and vasoconstrictive factors in patients with emotional stress-induced acute coronary syndrome during World Cup Soccer 2006. J Am Coll Cardiol. 2010;55(7):637-642.
15. Spieker LE, Noll G, Ruschitzka FT, Luscher TF. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J Am Coll Cardiol. 2001;37(6):1493-1505.
16. Gaggin HK, Truong QA, Gandhi PU, et al. Systematic Evaluation of Endothelin 1 Measurement Relative to Traditional and Modern Biomarkers for Clinical Assessment and Prognosis in Patients With Chronic Systolic Heart Failure: Serial Measurement and Multimarker Testing. Am J Clin Pathol. 2017;147(5):461-472.
17. Dmour BA, Costache AD, Dmour A, et al. Could Endothelin-1 Be a Promising Neurohormonal Biomarker in Acute Heart Failure? Diagnostics (Basel). 2023;13(13).
18. Levine GN, Lange RA, Bairey-Merz CN, et al. Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2017;6(10).
19. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337.
20. Kiran U. Effects of meditation on recovery after coronary artery bypass surgery. J Prev Cardiol. 2011;1.
21. Feuerstein G, Bodian S. Living yoga : a comprehensive guide for daily life. New York, NY: J.P. Tarcher/Perigee New York, NY; 1993.
22. Edinger JD, Fins AI, Goeke JM, et al. The empirical identification of insomnia subtypes: a cluster analytic approach. Sleep. 1996;19(5):398-411.
23. Fichten CS. Poor Sleepers Who Do Not Complain of Insomnia: Myths and Realities About Psychological and Lifestyle Characteristics of Older Good and Poor Sleepers Journal of Behavioral Medicine. 1995;18(2):189-223.
24. Lichstein KL, Wilson NM, Johnson CT. Psychological treatment of secondary insomnia. Psychol Aging. 2000;15(2):232-240.
25. Mander BA, Winer JR, Walker MP. Sleep and Human Aging. Neuron. 2017;94(1):19-36.
26. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370.
27. Millar K, Jelicic M, Bonke B, Asbury AJ. Assessment of preoperative anxiety: comparison of measures in patients awaiting surgery for breast cancer. Br J Anaesth. 1995;74(2):180-183.
28. Wallace RK, Benson H, Wilson AF. A wakeful hypometabolic physiologic state. Am J Physiol. 1971;221(3):795-799.
29. Benson H, Greenwood MM, Klemchuk H. The relaxation response: psychophysiologic aspects and clinical applications. Int J Psychiatry Med. 1975;6(1-2):87-98.
30. Levine GN, Lange RA, Bairey‐Merz CN, et al. Meditation and Cardiovascular Risk Reduction. Journal of the American Heart Association. 2017;6(10):e002218.
31. Lutz A, Slagter HA, Dunne JD, Davidson RJ. Attention regulation and monitoring in meditation. Trends Cogn Sci. 2008;12(4):163-169.
32. M G RB, Kadavigere R, Koteshwara P, Sathian B, Rai KS. Rajyoga Meditation Experience Induces Enhanced Positive Thoughts and Alters Gray Matter Volume of Brain Regions: A Cross-sectional Study. Mindfulness. 2021;12(7):1659-1671.
33. Salomone OA, Elliott PM, Calvino R, Holt D, Kaski JC. Plasma immunoreactive endothelin concentration correlates with severity of coronary artery disease in patients with stable angina pectoris and normal ventricular function. J Am Coll Cardiol. 1996;28(1):14-19.
34. Miyauchi T, Yanagisawa M, Tomizawa T, et al. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet. 1989;2(8653):53-54.
35. Stewart DJ, Kubac G, Costello KB, Cernacek P. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol. 1991;18(1):38-43.
36. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC, Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 1991;325(14):997-1001.
37. Vierhapper H, Wagner O, Nowotny P, Waldhausl W. Effect of endothelin-1 in man. Circulation. 1990;81(4):1415-1418.
38. Kaski JC, Cox ID, Crook JR, et al. Differential plasma endothelin levels in subgroups of patients with angina and angiographically normal coronary arteries. Coronary Artery Disease Research Group. Am Heart J. 1998;136(3):412-417.
39. Jankowich MD, Wu WC, Choudhary G. Association of Elevated Plasma Endothelin-1 Levels With Pulmonary Hypertension, Mortality, and Heart Failure in African American Individuals: The Jackson Heart Study. JAMA Cardiol. 2016;1(4):461-469.
40. Beghetti M, Black SM, Fineman JR. Endothelin-1 in congenital heart disease. Pediatr Res. 2005;57(5 Pt 2):16R-20R.
41. Zymlinski R, Sierpinski R, Metra M, et al. Elevated plasma endothelin-1 is related to low natriuresis, clinical signs of congestion, and poor outcome in acute heart failure. ESC Heart Fail. 2020;7(6):3536-3544.
42. Matheis G. Circulating endothelin in patients undergoing coronary artery bypass grafting Eur J Cardio-thorac Surg. 1995;9:269-274.
43. Hemsen A, Ahlborg G, Ottosson-Seeberger A, Lundberg JM. Metabolism of Big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21). Regul Pept. 1995;55(3):287-297.
44. Yanagisawa M, Kurihara H, Kimura S, Goto K, Masaki T. A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J Hypertens Suppl. 1988;6(4):S188-191.
45. Zanzmera P, Shukla G, Gupta A, et al. Effect of successful epilepsy surgery on subjective and objective sleep parameters--a prospective study. Sleep Med. 2013;14(4):333-338.
46. Ketterer MW, Bekkouche NS, Goldberg AD, McMahon RP, Krantz DS. Symptoms of anxiety and depression are correlates of angina pectoris by recent history and an ischemia-positive treadmill test in patients with documented coronary artery disease in the pimi study. Cardiovasc Psychiatry Neurol. 2011;2011:134040.
47. Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety Disorders and Cardiovascular Disease. Curr Psychiatry Rep. 2016;18(11):101.
48. Karlsen HR, Matejschek F, Saksvik-Lehouillier I, Langvik E. Anxiety as a risk factor for cardiovascular disease independent of depression: A narrative review of current status and conflicting findings. Health Psychol Open. 2021;8(1):2055102920987462.
49. Cohen BE, Edmondson D, Kronish IM. State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease. Am J Hypertens. 2015;28(11):1295-1302.
50. Ashton C, Jr., Whitworth GC, Seldomridge JA, et al. Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino). 1997;38(1):69-75.